
Lipocine LPCN
€ 2.06
4.08%
Quartalsbericht 2025-Q3
hinzugefügt 06.11.2025
Lipocine DSO 2011-2026 | LPCN
DSO Jährlich Lipocine
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | 3.76 M | 36.6 | 32.8 | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 3.76 M | 32.8 | 1.25 M |
DSO anderer Aktien in der Pharmaeinzelhändler
| Name | DSO | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
AgeX Therapeutics
AGE
|
186 | - | -10.17 % | $ 12.2 K | ||
|
I-Mab
IMAB
|
271 | - | - | $ 866 M | ||
|
Esperion Therapeutics
ESPR
|
99.7 | $ 3.13 | 0.55 % | $ 651 M | ||
|
Exelixis
EXEL
|
43.4 | $ 48.2 | 8.51 % | $ 13.1 B | ||
|
Midatech Pharma plc
MTP
|
204 | - | -18.52 % | $ 27.3 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
84.7 | - | - | $ 40.3 B | ||
|
Fortress Biotech
FBIO
|
115 | $ 2.53 | 2.85 % | $ 70.6 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
2.75 K | - | -1.52 % | $ 24.7 M | ||
|
Galapagos NV
GLPG
|
56.5 | $ 28.81 | 1.48 % | $ 2.69 B | ||
|
Genmab A/S
GMAB
|
97.9 | $ 27.95 | 1.5 % | $ 17.2 B | ||
|
Ionis Pharmaceuticals
IONS
|
20.5 | $ 77.0 | 2.33 % | $ 12.3 B | ||
|
Kamada Ltd.
KMDA
|
103 | $ 8.29 | 0.91 % | $ 260 M | ||
|
Kazia Therapeutics Limited
KZIA
|
28.7 | $ 13.58 | 0.97 % | $ 1.8 B | ||
|
Ligand Pharmaceuticals Incorporated
LGND
|
77.8 | $ 231.58 | -0.31 % | $ 4.24 B | ||
|
INmune Bio
INMB
|
19.9 K | $ 1.54 | - | $ 38.1 M | ||
|
Liquidia Corporation
LQDA
|
65.5 | $ 41.64 | 3.75 % | $ 3.58 B | ||
|
ACADIA Pharmaceuticals
ACAD
|
37.5 | $ 22.58 | 1.03 % | $ 3.74 B | ||
|
Mirum Pharmaceuticals
MIRM
|
70.6 | $ 107.36 | 1.46 % | $ 5.39 B | ||
|
MannKind Corporation
MNKD
|
26.2 | $ 3.61 | 26.17 % | $ 1.1 B | ||
|
Advaxis
ADXS
|
88.1 | - | -9.65 % | $ 45.9 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
28.1 | $ 3.46 | -1.14 % | $ 5.7 M | ||
|
Aeterna Zentaris
AEZS
|
146 | - | 5.93 % | $ 314 M | ||
|
Aeglea BioTherapeutics
AGLE
|
216 | - | - | $ 1.01 B | ||
|
CureVac N.V.
CVAC
|
13.6 | - | - | $ 867 M | ||
|
Applied Genetic Technologies Corporation
AGTC
|
0.114 | - | - | $ 26.5 M | ||
|
AIkido Pharma
AIKI
|
17.9 | - | 1.93 % | $ 17.4 M | ||
|
Aptinyx
APTX
|
46.9 | - | -39.0 % | $ 4.57 M | ||
|
Albireo Pharma
ALBO
|
14.7 | - | -0.23 % | $ 916 M | ||
|
Arcutis Biotherapeutics
ARQT
|
106 | $ 24.0 | 2.46 % | $ 3.05 B | ||
|
Alpine Immune Sciences
ALPN
|
154 | - | - | $ 2.17 B |